Our recent application for the MIT-Haalbaarheid was successful. This provides Kaminari Medical with 20k to support our feasibility activities.
Kaminari Medical is one of 42 start-ups selected from across Europe for the EIT Health Catapult Semi-finals.
We look forward to the training from experts and meeting with investors and corporates.
Semi Finals Pitch: December 2nd 2021
The ten winners of the prestigious Academic Startup Competition 2020 have been named as Bimini Biotech, DeNoize, Digi.Bio, IamFluidics, Kaminari Medical, Lusoco, NC Biomatrix, Taylor, uCrowds and VanBoven. The 10 winning startups can use the title ‘Best Academic Startup of 2020’ for the coming year.
The winning startups were chosen by an expert jury after a thrilling final in which all 20 finalists were asked to pitch. The ten winners were chosen on the basis of their value proposition, the innovative nature of their technology, the potential of their business and earnings model, and their team composition.
In addition to the title of ‘Best Academic Startup of 2020’ the startups will be introduced to a network of entrepreneurs, investors and other companies, and will have access a coaching programme with dedicated mentors.
Academic Startup Competition
The Academic Startup Competition is an initiative of the Association of Universities in the Netherlands (VSNU), the Dutch Federation of University Medical Centres, (NFU), Netherlands Academy of Technology and Innovation (AcTI) and Techleap.nl, and is supported by the Ministry of Economic Affairs and Climate Policy. The aim of the competition is to put valorisation and academic spinoffs in the spotlight.
‘I am looking forward to following how these entrepreneurs help make the world a little better,’ said deputy economic affairs minister Mona Keijzer. ‘As innovative startups, they help ensure the Netherlands is a world beater when it comes to innovation and entrepreneurship, and that we can continue to develop smart solutions, create jobs and strengthen our economy. They embody the slogan “for every global challenge, there is a
Pieter Duisenberg, chairman VSNU: ‘These fledgling companies show that the Netherlands’ academic startups have a pioneering role in creating ground-breaking innovations.
This underscores the importance of our key aim: to be the number 1 ecosystem for academic startups in Europe.’
Constantijn van Oranje, Teachleap.nl envoy: ‘These winners and this competition show that the Dutch academic startup ecosystem is bursting with energy and inventiveness. The time is now ripe to further professionalise the transfer of expertise in the Netherlands. Knowledge is not enough in itself. In the end it is the market that decides if a company is successful, not the technology, and this is why you need entrepreneurship as well.’
Margrethe Jonkman, chairwoman Netherlands Academy of Technology and Innovation (AcTI): ‘Economic activity and employment provide a solid starting position while innovative startups offer us the opportunity to advance into new areas. In congratulating these 10 winners, we are showing that we are both proud of them and of the ecosystem in which they
developed. At the same time, this ecosystem deserves our continual attention, because new challenges demand new solutions.’
Uniiq, the South Holland investment fund has invested €300,000 in Kaminari Medical for the further development of our imaging technology .
Jeroen Kodde, CEO of Kaminari Medical: “The investment from UNIIQ makes it possible for us to further develop our catheter for eventual use in patients. We have shown in the laboratory that the system works and we are now taking steps to improve the detection of these high-risk plaques in the clinic and, of course, their treatment.”
Kaminari Medical successfully attained 250k for the Take-off 2 funding for early phase projects from The Dutch Research Council (NWO) .
NLC -The European Healthtech Venture Builder has closed Momentum – a € 2.2 mln fund for private investments -within a month. This fund will be invested in 11 innovative healthtech ventures from NLC’s portfolio including Kaminari Medical. With this new way of funding, investors can easily spread their money and hence their risk, and at the same time build up a broad portfolio of startups.
Kaminari Medical was granted the EIT Headstart funding of €50k from EIT Health.
Kaminari Medical was granted Take-off 1 €40k from The Dutch Research Council (NWO) to complete a feasibility study on the commercial application of the IVPA technology.